泰和新材(002254.SZ):民士達申請於北交所上市獲證監會同意批覆
格隆匯3月16日丨泰和新材(002254.SZ)公佈,公司控股子公司煙台民士達特種紙業股份有限公司(“民士達”)於2023年3月16日收到中國證券監督管理委員會出具的《關於同意煙台民士達特種紙業股份有限公司向不特定合格投資者公開發行股票註冊的批覆》(證監許可[2023]537號),同意民士達向不特定合格投資者公開發行股票的註冊申請,具體內容如下:
“一、同意你公司向不特定合格投資者公開發行股票的註冊申請。
二、你公司本次發行股票應嚴格按照報送北京證券交易所的招股説明書和發行承銷方案實施。
三、本批覆自同意註冊之日起12個月內有效。
四、自同意註冊之日起至本次股票發行結束前,你公司如發生重大事項,應及時報吿北京證券交易所並按有關規定處理。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.